Apar Kishor Ganti, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Jazz Pharmaceuticals
    Topic: 
    SCLC RWE
    Date added: 
    12/12/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Astra Zeneca
    Topic: 
    Metastatic NSCLC
    Date added: 
    12/12/2023
    Relationship end date: 
    12/06/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Cardinal Health
    Topic: 
    Meeting highlights lung cancer
    Date added: 
    12/12/2023
    Relationship end date: 
    10/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Flagship Biosciences
    Topic: 
    HNSCC
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Regeneron Pharmaceuticals
    Topic: 
    NSCLC
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Mirati Therapeutics
    Topic: 
    KRAS G12C
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Beigene Ltd
    Topic: 
    NSCLC
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi Genzyme
    Topic: 
    NSCLC
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Takeda
    Topic: 
    IGF1-R
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    YmAbs Therapeutics
    Topic: 
    DSMC Chair
    Date added: 
    12/12/2023
    Relationship end date: 
    12/31/2022
Return to Iowa Hematology Oncology Conference: Emphasis on Precision-Guided Management